Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium (2009)

Peer-Reviewed Study · Stanford SC, Stanford BJ, Gillman PK · May 7, 2009

Stanford SC et al., 2009-05-07: Case report re-analysis: a patient on paroxetine until two days before parathyroidectomy developed a life-threatening postoperative delirium after intravenous methylene blue; the authors attribute it to monoamine oxidase inhibition and serotonin toxicity.

Methylene blue has been found to be a potent inhibitor of monoamine oxidase (MAO), and several cases of serotonin toxicity have been reported recently following its administration.

Stanford SC et al., 2009-05-07: Case report re-analysis: a patient on paroxetine until two days before parathyroidectomy developed a life-threatening postoperative delirium after intravenous methylene blue; the authors attribute it to monoamine oxidase inhibition and serotonin toxicity. Journal of Psychopharmacology 2010 Oct;24(10):1433-8; epub 2009-05-07. Type: single case report plus pharmacological review. N=1. Country: UK (University College London). Methylene blue dose/route: IV, used pre-operatively to visualise parathyroid glands (dose not stated in abstract). Funder: not stated in abstract. Declared conflicts: not stated in abstract (full text not accessed). Product maker: not stated. Comparator: none. Also filed as MTL-104, MTF-67 (claims C10, C7, F3). Study type: case report.